Lung Adenocarcinoma With Initially Co‐Occurring EGFR and BRAF Double Mutation: A Case Report and Literature Review
ABSTRACT Vrafmurine sarcoma viral oncogene homolog B (BRAF) mutations, including both V600E and non‐V600E variants, are infrequent in non‐small cell lung cancer (NSCLC), representing approximately 2% of lung adenocarcinomas. Activated BRAF mutations are regarded as an underappreciated oncogenic driv...
Saved in:
| Main Authors: | Lu Wang, Xueting Wang, Motong Xu, Yanan Wang, Lingxin Feng, Xue Yang, Jing Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.70031 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
by: Arianna Marinello, MD, et al.
Published: (2025-03-01) -
BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature
by: Marianna Peroni, MD, et al.
Published: (2025-08-01) -
A Case Report of Lung Adenocarcinoma with EGFR G719A Mutation
and LMNA-NTRK1 Fusion
by: Shiqi SONG, et al.
Published: (2025-01-01) -
BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01) -
A Novel Exon 19 EGFR mutation in a patient with lung adenocarcinoma: A Case Report and Literature Review
by: Laura Gutiérrez-Sainz, et al.
Published: (2025-06-01)